Key result
Metabolic syndrome is linked to significantly higher blood and plasma viscosity in early-stage hypertension.
Cross-Sectional (n=156)
Answers are grounded in this paper and cite their sources.
We examined whether hemorheology and platelet function are affected in essential hypertensives (EHTs) of the World Health Organization stage I when complicated with metabolic syndrome (Mets). In 156 untreated EHTs, blood viscosity and platelet surface markers were determined. Blood viscosity was significantly elevated in 54 subjects with Mets compared with 102 subjects without Mets. Hematocrit and plasma viscosity increased in the group with Mets, although red blood cell rigidity index "k" did not differ between groups. As a whole group, blood viscosity correlated positively with hematocrit and plasma viscosity. Additionally, plasma viscosity correlated positively with plasma leptin, triglyceride, homeostasis model assessment index, C-reactive protein, and plasma fibrinogen, but negatively with high-density lipoprotein cholesterol. In contrast, no differences were seen in platelet surface markers between groups. In conclusion, EHTs of the early stage complicated with Mets are characterized by increased blood viscosity due to hemoconcentration and increased plasma viscosity.
No takes yet. Share an insight, caveat, or question.
Sugimori et al. (2012) conducted a cross-sectional in Essential hypertension (n=156). Metabolic syndrome vs. Without metabolic syndrome was evaluated on Blood viscosity and platelet surface markers. Metabolic syndrome in early-stage essential hypertension is associated with significantly increased blood viscosity and plasma viscosity compared to those without metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: